80 related articles for article (PubMed ID: 9142215)
1. Loss of heterozygosity at the N-ras locus in 7,12-dimethylbenz[a] anthracene-induced rat leukemia.
Osaka M; Matsuo S; Koh T; Sugiyama T
Mol Carcinog; 1997 Apr; 18(4):206-12. PubMed ID: 9142215
[TBL] [Abstract][Full Text] [Related]
2. Specific N-ras mutation in bone marrow within 48 H of 7,12-dimethylbenz[a]anthracene treatment in Huggins-Sugiyama rat leukemogenesis.
Osaka M; Matsuo S; Koh T; Sugiyama T
Mol Carcinog; 1996 Jul; 16(3):126-31. PubMed ID: 8688147
[TBL] [Abstract][Full Text] [Related]
3. The specific N-ras mutation in rat 7,12-dimethylbenz[a]anthracene (DMBA)-induced leukemia.
Osaka M; Koh T; Matsuo S; Sugiyama T
Leukemia; 1997 Apr; 11 Suppl 3():393-5. PubMed ID: 9209402
[TBL] [Abstract][Full Text] [Related]
4. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
[TBL] [Abstract][Full Text] [Related]
5. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
Haag JD; Hsu LC; Newton MA; Gould MN
Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of DMBA-induced early in vivo ras expression.
Gyöngyi Z; Grama L; Nádasi E; Sándor J; Németh A; Varga C; Kiss I; Ember I
In Vivo; 2002; 16(5):323-6. PubMed ID: 12494871
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat erythroleukemia cell lines.
Koh T; Osaka M; Sugiyama T
Leukemia; 1997 Apr; 11 Suppl 3():482-3. PubMed ID: 9209432
[TBL] [Abstract][Full Text] [Related]
8. Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells.
Sasaki K; Bertrand O; Nakazawa H; Fitzgerald DJ; Mironov N; Yamasaki H
Cancer Res; 1995 Aug; 55(16):3513-6. PubMed ID: 7627957
[TBL] [Abstract][Full Text] [Related]
9. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
[TBL] [Abstract][Full Text] [Related]
10. N-ras mutation in 7,12-dimethylbenz[a]anthracene (DMBA)-induced erythroleukemia in Long-Evans rats.
Osaka M; Matsuo S; Koh T; Liang P; Kinoshita H; Maeda S; Sugiyama T
Cancer Lett; 1995 May; 91(1):25-31. PubMed ID: 7750091
[TBL] [Abstract][Full Text] [Related]
11. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis.
Ise K; Nakamura K; Nakao K; Shimizu S; Harada H; Ichise T; Miyoshi J; Gondo Y; Ishikawa T; Aiba A; Katsuki M
Oncogene; 2000 Jun; 19(26):2951-6. PubMed ID: 10871846
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
[TBL] [Abstract][Full Text] [Related]
13. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
Kumar R; Angelini S; Hemminki K
Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
[TBL] [Abstract][Full Text] [Related]
14. 7,12-DMBA-induced rat leukemia: a review with insights into future research.
Sugiyama T; Osaka M; Koami K; Maeda S; Ueda N
Leuk Res; 2002 Dec; 26(12):1053-68. PubMed ID: 12443876
[TBL] [Abstract][Full Text] [Related]
15. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J
Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761
[TBL] [Abstract][Full Text] [Related]
16. Absence of Ras mutations in rat DMBA-induced mammary tumors.
Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
[TBL] [Abstract][Full Text] [Related]
17. Point mutation of the ras protooncogenes and chromosome aberrations in acute nonlymphocytic leukemia and preleukemia related to therapy with alkylating agents.
Pedersen-Bjergaard J; Janssen WG; Lyons J; Philip P; Bartram CR
Cancer Res; 1988 Apr; 48(7):1812-7. PubMed ID: 3280121
[TBL] [Abstract][Full Text] [Related]
18. Establishment and chromosome studies of in vitro lines of chemically induced rat erythroblastic leukemia cells.
Maeda S; Uenaka H; Ueda N; Shiraishi N; Suglyama T
J Natl Cancer Inst; 1980 Mar; 64(3):539-46. PubMed ID: 6766514
[TBL] [Abstract][Full Text] [Related]
19. ras and p53 genes are infrequently involved in N-nitroso-N-butylurea (NBU)-induced rat leukemia.
Osaka M; Tsuruyama T; Koami K; Matsuo S; Sugiyama T
Cancer Lett; 1998 Feb; 124(2):199-204. PubMed ID: 9500211
[TBL] [Abstract][Full Text] [Related]
20. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
